René Snacken
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
René Snacken has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Caroline Brown
Senior expert, European Centre for Disease prevention and Control and WHO Regional Office for Europe
2 shared publicationsPhillip Zucs
Unit of Surveillance and Response Support, European Centre for Disease Prevention and Control, Stockholm, Sweden
2 shared publicationsA. J. Amato-Gauci
European Centre for Disease Prevention and Control (ECDC),Stockholm,Sweden
1 shared publication- Amadou Bailo Diallo
World Health Organization, Country Office, Lomé BP 1504, Togo
1 shared publication - Aminata Tolno
Bureau de Pays de l'Organisation Mondiale de la Santé pour la Guinée, Immeuble BAH, Quartier Cameroun, BP: 817, Conakry, Guinea
1 shared publication Andrew Amato-Gauci
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
1 shared publication
Latest Publications
- Open Access
- 6 July 2018
- Published by Springer Nature in BMC Health Services Research
- Vol. 18 (1) , 528
Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states
EU Decision 1082/2013/EU on serious cross-border health threats provides a legal basis for collaboration between EU Member States, and between international and European level institutions on preparedness, prevention, and mitigation in the event of a public health emergency. The Decision provides a context for the present study, which aims to identify good practices and lessons learned in preparedness and response to Middle East Respiratory Syndrome (MERS) (in UK, Greece, and Spain) and poliomyelitis (in Poland and Cyprus). Based on a documentary review, followed by five week-long country visits involving a total of 61 interviews and group discussions with experts from both the health and non-health sectors, this qualitative case study has investigated six issues related to preparedness and response to MERS and poliomyelitis: national plans and overall preparedness capacity; training and exercises; risk communication; linking policy and implementation; interoperability between the health and non-health sectors; and cross-border collaboration. Preparedness and response plans for MERS and poliomyelitis were in place in the participating countries, with a high level of technical expertise available to implement them. Nevertheless, formal evaluation of the responses to previous public health emergencies have sometimes been limited, so lessons learned may not be reflected in updated plans, thereby risking mistakes being repeated in future. The nature and extent of inter-sectoral collaboration varied according to the sectors involved, with those sectors that have traditionally had good collaboration (e.g. animal health and food safety), as well as those that have a financial incentive for controlling infectious diseases (e.g. agriculture, tourism, and air travel) seen as most likely to have integrated public health preparedness and response plans. Although the formal protocols for inter-sectoral collaboration were not always up to date, good personal relations were reported within the relevant professional networks, which could be brought into play in the event of a public health emergency. Cross-border collaboration was greatly facilitated if the neighbouring country was a fellow EU Member State. Infectious disease outbreaks remain as an ongoing threat. Efforts are required to ensure that core public health capacities for the full range of preparedness and response activities are sustained.
- 6 July 2018
- Published by Springer Nature in BMC Health Services Research
- Vol. 18 (1) , 528
Open AccessPreparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states
EU Decision 1082/2013/EU on serious cross-border health threats provides a legal basis for collaboration between EU Member States, and between international and European level institutions on preparedness, prevention, and mitigation in the event of a public health emergency. The Decision provides a context for the present study, which aims to identify good practices and lessons learned in preparedness and response to Middle East Respiratory Syndrome (MERS) (in UK, Greece, and Spain) and poliomyelitis (in Poland and Cyprus). Based on a documentary review, followed by five week-long country visits involving a total of 61 interviews and group discussions with experts from both the health and non-health sectors, this qualitative case study has investigated six issues related to preparedness and response to MERS and poliomyelitis: national plans and overall preparedness capacity; training and exercises; risk communication; linking policy and implementation; interoperability between the health and non-health sectors; and cross-border collaboration. Preparedness and response plans for MERS and poliomyelitis were in place in the participating countries, with a high level of technical expertise available to implement them. Nevertheless, formal evaluation of the responses to previous public health emergencies have sometimes been limited, so lessons learned may not be reflected in updated plans, thereby risking mistakes being repeated in future. The nature and extent of inter-sectoral collaboration varied according to the sectors involved, with those sectors that have traditionally had good collaboration (e.g. animal health and food safety), as well as those that have a financial incentive for controlling infectious diseases (e.g. agriculture, tourism, and air travel) seen as most likely to have integrated public health preparedness and response plans. Although the formal protocols for inter-sectoral collaboration were not always up to date, good personal relations were reported within the relevant professional networks, which could be brought into play in the event of a public health emergency. Cross-border collaboration was greatly facilitated if the neighbouring country was a fellow EU Member State. Infectious disease outbreaks remain as an ongoing threat. Efforts are required to ensure that core public health capacities for the full range of preparedness and response activities are sustained.
- Open Access
- 24 April 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 304
Lessons learned by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: a case series
By the end of the 2013–2016 West African Ebola Virus Disease (EVD) outbreaks, a total of 3814 cases (probable and confirmed) and 2544 deaths were reported in Guinea. Clearly, surveillance activities aiming at stopping human-to-human transmission have been the breakthrough of EVD outbreak management, but their application has been at times easier said than done. This article presents five confirmed or probable EVD cases that arose in Conakry towards the end of the Guinea epidemic, which demonstrate flaws in surveillance and follow-up. For case 1, safe burial requirements were not followed. For cases 1 and 2, negative Polymerase Chain Reaction (PCR) results were interpreted as no infection. For the first case, the sample may have not been taken properly while for the second the disease was possibly at its early stage. Case 3 was stopped at a border health checkpoint and despite her high temperature she was allowed to continue the bus journey. For case 4, an oral swab sample was supposedly taken after death but could not be found for retrospective testing. Despite characteristic symptomatology, case 5 was not identified as a suspect case for as long as 3 weeks. In epidemic contexts, health systems must be able to track all samples of suspect cases and deaths, regardless of their laboratory results. Social mobilization in communities and training in health care facilities must be strengthened at the tail of an outbreak, to avoid the natural slackening of disease surveillance, in particular for long-lasting and deadly epidemics.
- 24 April 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 304
Open AccessLessons learned by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: a case series
By the end of the 2013–2016 West African Ebola Virus Disease (EVD) outbreaks, a total of 3814 cases (probable and confirmed) and 2544 deaths were reported in Guinea. Clearly, surveillance activities aiming at stopping human-to-human transmission have been the breakthrough of EVD outbreak management, but their application has been at times easier said than done. This article presents five confirmed or probable EVD cases that arose in Conakry towards the end of the Guinea epidemic, which demonstrate flaws in surveillance and follow-up. For case 1, safe burial requirements were not followed. For cases 1 and 2, negative Polymerase Chain Reaction (PCR) results were interpreted as no infection. For the first case, the sample may have not been taken properly while for the second the disease was possibly at its early stage. Case 3 was stopped at a border health checkpoint and despite her high temperature she was allowed to continue the bus journey. For case 4, an oral swab sample was supposedly taken after death but could not be found for retrospective testing. Despite characteristic symptomatology, case 5 was not identified as a suspect case for as long as 3 weeks. In epidemic contexts, health systems must be able to track all samples of suspect cases and deaths, regardless of their laboratory results. Social mobilization in communities and training in health care facilities must be strengthened at the tail of an outbreak, to avoid the natural slackening of disease surveillance, in particular for long-lasting and deadly epidemics.
- Open Access
- 21 October 2014
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 24 (eLetters S)
New developments of influenza surveillance in Europe
Collaboration among European countries for creating a harmonised network of influenza surveillance started in the 1990s and has evolved incrementally with additional countries and extended objectives1. Since 2008, the European Influenza Surveillance Network (EISN) covering 30 EU/EAA countries has been managed by the European Centre for Disease Prevention and Control (ECDC), Sweden. In parallel, the WHO Regional Office for Europe, Denmark, was covering the 53 countries of the European Region, including all the EU/EEA countries. In this structure, countries initially reported data derived from sentinel and other clinical and laboratory surveillance systems via two different platforms. Both agencieshave also published two separate bulletins (the Weekly Influenza Surveillance Overview and Euroflu, respectively) with unavoidable discrepancies2.In 2010, the European Surveillance System (TESSy), was established at ECDCas a single data entry point in order to synchronize reporting for both platforms3. Starting from the 2014-2015 influenza season, based on feedback from key stakeholders, ECDC and the WHO Regional Office for Europe have decided to publish a single joint influenza bulletin for the WHO European Region and EU/EEA Member States. All 53 European countries have been invited to report through the single joint entry point to TESSy,ECDC'system for reporting data. Data from TESSy are then used to publish the joint weekly bulletin in English and Russian. Data transfer to WHO global platforms FluNet and FluID will continue to be managed by the WHO Regional Office for Europe.For optimising this transition, a training course was organised just afterthe fourth joint WHO European Region and ECDC Annual Influenza Surveillance Meeting4 that was held on 11- 13 June, 2014 in Vienna, Austria. New users are being trained to enter data to TESSy. During the first season of the new bulletin, new options will be included,for instance a format for interactive consultation by country, better description of data sets from different surveillance systems (e.g. surveillance of hospitalised cases and virus detections in samples from sentinel vs. non-sentinel systems). Data from other relevant surveillance initiatives will continue to be included, e.g. vaccine coverage, effectiveness and mortality5. This new bulletin is available since October2014 at http://www. flunewseurope.org/.Looking to future seasons, inclusion of additional topics will be considered, including expansion of data on other respiratory pathogens such as respiratory virus (RSV) and the possible inclusion of other emerging pathogens such as Middle East Respiratory Syndrome Coronavirus (MERS-CoV), sero-surveillance and expanded sequence-based molecular surveillance.Finally, activities will continue to be streamlined by means of annual influenza surveillance meetings, a coordination group consisting of experts, ad hoc working groups to tackle specific topics, and a range of laboratory strengthening activities including EQA and training. In conclusion, from week 40 in 2014, 53 European countries will have the opportunity to report influenza surveillance data to a single platform with the analysis posted in a new European joint weekly bulletin as well as in the WHO global influenza update. Extended influenza surveillance in Europe will provide more data to better estimate the burden of the disease.
- 21 October 2014
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 24 (eLetters S)
Open AccessNew developments of influenza surveillance in Europe
Collaboration among European countries for creating a harmonised network of influenza surveillance started in the 1990s and has evolved incrementally with additional countries and extended objectives1. Since 2008, the European Influenza Surveillance Network (EISN) covering 30 EU/EAA countries has been managed by the European Centre for Disease Prevention and Control (ECDC), Sweden. In parallel, the WHO Regional Office for Europe, Denmark, was covering the 53 countries of the European Region, including all the EU/EEA countries. In this structure, countries initially reported data derived from sentinel and other clinical and laboratory surveillance systems via two different platforms. Both agencieshave also published two separate bulletins (the Weekly Influenza Surveillance Overview and Euroflu, respectively) with unavoidable discrepancies2.In 2010, the European Surveillance System (TESSy), was established at ECDCas a single data entry point in order to synchronize reporting for both platforms3. Starting from the 2014-2015 influenza season, based on feedback from key stakeholders, ECDC and the WHO Regional Office for Europe have decided to publish a single joint influenza bulletin for the WHO European Region and EU/EEA Member States. All 53 European countries have been invited to report through the single joint entry point to TESSy,ECDC'system for reporting data. Data from TESSy are then used to publish the joint weekly bulletin in English and Russian. Data transfer to WHO global platforms FluNet and FluID will continue to be managed by the WHO Regional Office for Europe.For optimising this transition, a training course was organised just afterthe fourth joint WHO European Region and ECDC Annual Influenza Surveillance Meeting4 that was held on 11- 13 June, 2014 in Vienna, Austria. New users are being trained to enter data to TESSy. During the first season of the new bulletin, new options will be included,for instance a format for interactive consultation by country, better description of data sets from different surveillance systems (e.g. surveillance of hospitalised cases and virus detections in samples from sentinel vs. non-sentinel systems). Data from other relevant surveillance initiatives will continue to be included, e.g. vaccine coverage, effectiveness and mortality5. This new bulletin is available since October2014 at http://www. flunewseurope.org/.Looking to future seasons, inclusion of additional topics will be considered, including expansion of data on other respiratory pathogens such as respiratory virus (RSV) and the possible inclusion of other emerging pathogens such as Middle East Respiratory Syndrome Coronavirus (MERS-CoV), sero-surveillance and expanded sequence-based molecular surveillance.Finally, activities will continue to be streamlined by means of annual influenza surveillance meetings, a coordination group consisting of experts, ad hoc working groups to tackle specific topics, and a range of laboratory strengthening activities including EQA and training. In conclusion, from week 40 in 2014, 53 European countries will have the opportunity to report influenza surveillance data to a single platform with the analysis posted in a new European joint weekly bulletin as well as in the WHO global influenza update. Extended influenza surveillance in Europe will provide more data to better estimate the burden of the disease.
- Open Access
- 1 January 2014
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 142 (9) , 1809-1812
Influenza season 2012–2013 in Europe: moderate intensity, mixed (sub)types
SUMMARY: This paper summarizes influenza activity in the European Union/European Economic Area (EU/EEA) in 2012–2013. The influenza season 2012–2013 in Europe lasted from early December to late April. Overall the severity of the season could be described as moderate, based on the ILI/ARI consultation rates and the percentage of sentinel specimens positive for influenza compared to previous seasons. Both influenza A and B viruses circulating accounted for 47% and 53% of positive sentinel specimens, respectively, with both A(H1) and A(H3) varying for dominance. Compared to outpatients, the proportion of laboratory-confirmed influenza hospitalized cases infected by A(H1N1)pdm09 was significantly higher in middle-aged patients (33%vs. 17%,χ2 = 66·6,P < 0·01). Despite a relatively good match between vaccine and circulating strains, vaccine effectiveness was estimated to be moderate.
- 1 January 2014
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 142 (9) , 1809-1812
Open AccessInfluenza season 2012–2013 in Europe: moderate intensity, mixed (sub)types
SUMMARY: This paper summarizes influenza activity in the European Union/European Economic Area (EU/EEA) in 2012–2013. The influenza season 2012–2013 in Europe lasted from early December to late April. Overall the severity of the season could be described as moderate, based on the ILI/ARI consultation rates and the percentage of sentinel specimens positive for influenza compared to previous seasons. Both influenza A and B viruses circulating accounted for 47% and 53% of positive sentinel specimens, respectively, with both A(H1) and A(H3) varying for dominance. Compared to outpatients, the proportion of laboratory-confirmed influenza hospitalized cases infected by A(H1N1)pdm09 was significantly higher in middle-aged patients (33%vs. 17%,χ2 = 66·6,P < 0·01). Despite a relatively good match between vaccine and circulating strains, vaccine effectiveness was estimated to be moderate.
- Open Access
- 13 July 2012
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 6 (6) , e93-e96
Surveillance of hospitalised severe cases of influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010–2011
Please cite this paper as: Snacken et al. (2012) Surveillance of hospitalised severe cases of Influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010–2011. Influenza and Other Respiratory Viruses 6(601), e93–e96. A few months into the 2009 influenza pandemic, nine European countries implemented case-based surveillance of hospitalised severe influenza infections. In the present study, we assess the association between patient characteristics, in particular underlying conditions, and the severity level of influenza A(H1N1)pdm09 infection during the 2010-2011 season. Patient age, the presence of underlying conditions, pneumonia, acute respiratory distress syndrome (ARDS) and the need for ventilation were significantly associated with the severity of influenza A(H1N1)pdm09 infection. Despite limitations essentially because of the heterogeneity of the data reported, this study provides insight into severe influenza cases.
- 13 July 2012
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 6 (6) , e93-e96
Open AccessSurveillance of hospitalised severe cases of influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010–2011
Please cite this paper as: Snacken et al. (2012) Surveillance of hospitalised severe cases of Influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010–2011. Influenza and Other Respiratory Viruses 6(601), e93–e96. A few months into the 2009 influenza pandemic, nine European countries implemented case-based surveillance of hospitalised severe influenza infections. In the present study, we assess the association between patient characteristics, in particular underlying conditions, and the severity level of influenza A(H1N1)pdm09 infection during the 2010-2011 season. Patient age, the presence of underlying conditions, pneumonia, acute respiratory distress syndrome (ARDS) and the need for ventilation were significantly associated with the severity of influenza A(H1N1)pdm09 infection. Despite limitations essentially because of the heterogeneity of the data reported, this study provides insight into severe influenza cases.
- Open Access
- 3 December 2010
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 21 (5) , 674-675
Influenza surveillance in Europe
In the viewpoint entitled ‘Potential for greater coherence in EUROPEAN influenza surveillance’ and published in your last edition, EJPH 2010, 20(5):488–9, Johnson H et al. analysed the publically available data on influenza surveillance reported in the European Influenza Surveillance Network (EISN, formerly European Influenza Surveillance Scheme (EISS)) managed by the European Centre for Disease Prevention and Control (ECDC) and in the EuroFlu managed by WHO – Europe. The former agency reports data from 27 European Union (EU) countries and two European Economic Area (EEA) countries, and the latter collects data from 53 countries from the WHO European Region (that include the former countries). During the period 2009–10, the authors correctly observed that 7% of the data from the countries reporting in both bulletins were contradictory. The authors suggested some hypotheses to explain these discrepancies, from different data uploaded to different national contact points for reporting in some countries. Both ECDC and WHO – EURO have been aware of such differences. While small, they are being addressed in our ongoing coordination for quality assurance. An important improvement that should lead to a decreased number of these discrepancies is the new reporting technical solution introduced by European Centre for Disease Prevention and Control (EDCD) and WHO – Europe. As of January 2010 the reporting for the 29 EU/EEA countries is now synchronized and uses a single data entry point for both platforms. In addition, as a further step towards coordinated surveillance of influenza at the European level, in May 2011, ECDC and WHO – Europe will for the first time organize a joint annual meeting of their influenza surveillance network members where the influenza surveillance activities, including the validity and quality of the data and the analyses will be discussed. Beginning with the 2010–11 influenza season WHO – EURO and ECDC are now jointly reviewing weekly bulletins from both agencies, and we are writing joint guidance on human influenza surveillance. Taken together, these activities should improve the quality of the influenza data in Europe in the future.
- 3 December 2010
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 21 (5) , 674-675
Open AccessInfluenza surveillance in Europe
In the viewpoint entitled ‘Potential for greater coherence in EUROPEAN influenza surveillance’ and published in your last edition, EJPH 2010, 20(5):488–9, Johnson H et al. analysed the publically available data on influenza surveillance reported in the European Influenza Surveillance Network (EISN, formerly European Influenza Surveillance Scheme (EISS)) managed by the European Centre for Disease Prevention and Control (ECDC) and in the EuroFlu managed by WHO – Europe. The former agency reports data from 27 European Union (EU) countries and two European Economic Area (EEA) countries, and the latter collects data from 53 countries from the WHO European Region (that include the former countries). During the period 2009–10, the authors correctly observed that 7% of the data from the countries reporting in both bulletins were contradictory. The authors suggested some hypotheses to explain these discrepancies, from different data uploaded to different national contact points for reporting in some countries. Both ECDC and WHO – EURO have been aware of such differences. While small, they are being addressed in our ongoing coordination for quality assurance. An important improvement that should lead to a decreased number of these discrepancies is the new reporting technical solution introduced by European Centre for Disease Prevention and Control (EDCD) and WHO – Europe. As of January 2010 the reporting for the 29 EU/EEA countries is now synchronized and uses a single data entry point for both platforms. In addition, as a further step towards coordinated surveillance of influenza at the European level, in May 2011, ECDC and WHO – Europe will for the first time organize a joint annual meeting of their influenza surveillance network members where the influenza surveillance activities, including the validity and quality of the data and the analyses will be discussed. Beginning with the 2010–11 influenza season WHO – EURO and ECDC are now jointly reviewing weekly bulletins from both agencies, and we are writing joint guidance on human influenza surveillance. Taken together, these activities should improve the quality of the influenza data in Europe in the future.
- Open Access
- 29 September 2010
- Published by Springer Nature in Archives of Public Health
- Vol. 68 (3) , 85-86
Lessons learned from the 2009 influenza A(H1N1) pandemic at EU level
- 29 September 2010
- Published by Springer Nature in Archives of Public Health
- Vol. 68 (3) , 85-86
Open AccessLessons learned from the 2009 influenza A(H1N1) pandemic at EU level